Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells

Oncogene

Volumn 25, Issue 55, 2006, Pages 7311-7323

  Wang, G ^a   Jones, S J M ^a   Marra, M A ^a   Sadar, M D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Affymetrix; Androgen receptor; Cross talk; LNCaP hollow fiber model; PKA; Prostate cancer

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENOME; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANDROGENS; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION PROFILING; HUMANS; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 33751326982     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209715     Document Type: Article

References (63)

1. Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW et al. (1999). J Natl Cancer Inst 91: 1869-1876.
2. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S et al. (2000). Cancer Res 60: 6134-6141.
3. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, Whitesell L et al. (1994). Proc Natl Acad Sci USA 91: 5330-5334.
4. Bouchal J, Baumforth KR, Svachova M, Murray PG, von Angerer E, Kolar Z. (2005). J Pharm Pharmacol 57: 83-92.
5. Chen T, Cho RW, Stork PJ, Weber MJ. (1999). Cancer Res 59: 213-218.
6. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkmann AO, Trapman J. (1996). J Biol Chem 271: 6379-6388.
7. Cox ME, Deeble PD, Bissonette EA, Parsons SJ. (2000). J Biol Chem 275: 13812-13818.
8. Culig Z, Hobisch A, Hittmair A, Cronauer MV, Radmayr C, Zhang J et al. (1997). Prostate 32: 106-114.
9. Daga A, Micol V, Hess D, Aebersold R, Attardi G. (1993). J Biol Chem 268: 8123-8130.
10. Daniel PB, Walker WH, Habener JF. (1998). Annu Rev Nutr 18: 353-383.
11. Day CL, Puthalakath H, Skea G, Strasser A, Barsukov I, Lian LY et al. (2004). Biochem J 377: 597-605.
12. Debes JD, Tindall DJ. (2004). N Engl J Med 351: 1488-1490.
13. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M et al. (2002). Genome Biol 3: RESEARCH0032.
14. Dotzlaw H, Moehren U, Mink S, Cato AC, Iniguez Lluhi JA, Baniahmad A. (2002). Mol Endocrinol 16: 661-673.
15. Farini D, Puglianiello A, Mammi C, Siracusa G, Moretti C. (2003). Endocrinology 144: 1631-1643.
16. Gobert GN, Hueser CN, Curran EM, Sun QY, Glinsky VV, Welshons WV et al. (2001). Histochem Cell Biol 115: 381-395.
17. Goldstein JL, Brown MS. (1990). Nature 343: 425-430.
18. Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L et al. (2004). Am J Pathol 164: 217-227.
19. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L et al. (1980). Prog Clin Biol Res 37: 115-132.
20. Huggins C, Hodges CV. (2002). J Urol 168: 9-12.
21. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). CA Cancer J Clin 55: 10-30.
22. Jung M, Romer A, Keyszer G, Lein M, Kristiansen G, Schnorr D et al. (2003). Prostate 55: 89-98.
23. Kemppainen JA, Lane MV, Sar M, Wilson EM. (1992). J Biol Chem 267: 968-974.
24. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I et al. (1995). Endocrinology 136: 796-803.
25. Morris DI, Robbins JD, Ruoho AE, Sutkowski EM, Seamon KB. (1991). J Biol Chem 266: 13377-13384.
26. Nakhla AM, Leonard J, Hryb DJ, Rosner W. (1999). Steroids 64: 213-216.
27. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S et al. (2004). J Biol Chem 279: 1310-1322.
28. Nazareth LV, Weigel NL. (1996). J Biol Chem 271: 19900-19907.
29. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J et al. (2002). Proc Natl Acad Sci USA 99: 11890-11895.
30. Prins GS. (2000). Mayo Clin Proc 75(Suppl): S32-S35.
31. Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J. (1991). Mol Endocrinol 5: 1921-1930.
32. Robles LD, Frost AR, Davila M, Hutson AD, Grizzle WE, Chakrabarti R. (2002). J Biol Chem 277: 25431-25438.
33. Roche PJ, Hoare SA, Parker MG. (1992). Mol Endocrinol 6: 2229-2235.
34. Rokhlin OW, Taghiyev AF, Guseva NV, Glover RA, Chumakov PM, Kravchenko JE et al. (2005). Oncogene 24: 6773-6784.
35. Sadar MD, Akopian VA, Beraldi E. (2002). Mol Cancer Ther 1: 629-637.
36. Sadar MD, Hussain M, Bruchovsky N. (1999). Endocr Relat Cancer 6: 487-502.
37. Sadar MD. (1999). J Biol Chem 274: 7777-7783.
38. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR. (1996). J Biol Chem 271: 7043-7051.
39. Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W et al. (2002). Oncogene 21: 8749-8758.
40. Shah GV, Rayford W, Noble MJ, Austenfeld M, Weigel J, Vamos S et al. (1994). Endocrinology 134: 596-602.
41. Shenk JL, Fisher CJ, Chen SY, Zhou XF, Tillman K, Shemshedini L. (2001). J Biol Chem 276: 38472-38479.
42. Sramkoski RM, Pretlow II TG, Giaconia JM, Pretlow TP, Schwartz S, Sy MS et al. (1999). In vitro Cell Dev Biol Anim 35: 403-409.
43. Stroud RM, Walter P. (1999). Curr Opin Struct Biol 9: 754-759.
44. Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ. (2001). Genes Dev 15: 1796-1807.
45. Tasken K, Aandahl EM. (2004). Physiol Rev 84: 137-167.
46. Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L, Lee LF et al. (2002). Cancer Res 62: 6606-6614.
47. Tusher VG, Tibshirani R, Chu G. (2001). Proc Natl Acad Sci USA 98: 5116-5121.
48. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL et al. (2003). Prostate 57: 205-225.
49. Van Patten SM, Ng DC, Th'ng JP, Angelos KL, Smith AJ, Walsh DA. (1991). Proc Natl Acad Sci USA 88: 5383-5387.
50. Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J et al. (1999). Oncogene 18: 127-137.
51. Vilaboa N, Bermejo R, Martinez P, Bornstein R, Cales C. (2004). Nucl Acids Res 32: 6454-6467.
52. Waghray A, Feroze F, Schober MS, Yao F, Wood C, Puravs E et al. (2001). Proteomics 1: 1327-1338.
53. Wang G, Sadar MD. (2006). J Cell Biochem 98: 36-53.
54. Wright ME, Tsai MJ, Aebersold R. (2003). Mol Endocrinol 17: 1726-1737.
55. Xu LL, Su YP, Labiche R, Segawa T, Shanmugam N, McLeod DG et al. (2001). Int J Cancer 92: 322-328.
56. Yan Z, DeGregori J, Shohet R, Leone G, Stillman B, Nevins JR et al. (1998). Proc Natl Acad Sci USA 95: 3603-3608.
57. Young CY, Andrews PE, Montgomery BT, Tindall DJ. (1992). Biochemistry 31: 818-824.
58. Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ. (1991). Cancer Res 51: 3748-3752.
59. Zeng C. (2000). Microsc Res Tech 49: 467-477.
60. Zhang M, Magit D, Sager R. (1997). Proc Natl Acad Sci USA 94: 5673-5678.
61. Zhou ZX, Lane MV, Kemppainen JA, French FS, Wilson EM. (1995). Mol Endocrinol 9: 208-218.
62. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW et al. (2000). J Biol Chem 275: 6051-6054.
63. Zou Z, Zhang W, Young D, Gleave MG, Rennie P, Connell T et al. (2002). Clin Cancer Res 8: 1172-1177.